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CytotoxicityPeptaibiotics, non-ribosomally synthetized peptides from various ascomycetes, are uniquely characterized by di-
alkylatedα-amino acids, a rigid helical conformation, andmembrane permeation properties. Although generally
considered as antimicrobial peptides, peptaibiotics may display other toxicological properties, and their function
is in many cases unknown. With the goal to deﬁne the biological activity and selectivity of the peptaibiotic
trichogin GA IV from the human opportunist Trichoderma longibrachiatum we analyzed its membrane interac-
tion, cytotoxic activity and antibacterial effect. Trichogin GA IV effectively killed several types of healthy and
neoplastic human cells at doses (EC 50%=4–6 μM) lacking antibiotic effects on both Gram− andGram+bacteria
(MIC N 64 μM). The peptaibiotic distinctive C-terminal primary alcohol was found to cooperate with the
N-terminal n-octanoyl group to permeate the membrane phospholipid bilayer and to mediate effective binding
and active endocytosis of trichogin GA IV in eukaryotic cells, two steps essential for cell death induction.
Replacement of one Gly with Lys plus the simultaneous esteriﬁcation of the C-terminus, strongly increased
trichogin GA IV anti-Gram+ activity (MIC 1–4 μM), but further mitigated its cytotoxicity on human cells.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Peptaibiotics [1–4], a family of fungal peptides, share a high content
of α-aminoisobutyric acid (Aib) and other non-coded residues
conferring them a stable helical structure, which is responsible for
their ability to interact with phospholipid membranes. Their sequences
are also characterized by an acyl group at the N-terminus and a 1,2-
aminoalcohol at the C-terminus. For this reason these peptides are
also named peptaibols. In the past, much effort was devoted to their
isolation, structure elucidation, synthesis and antimicrobial activity
determination, aiming at ﬁnding new antibiotic drugs [1]. However, an-
tiviral, antiparasitic, immunosuppressive, anticoagulant andneuroleptic
effects of various peptaibiotics have also been described [4,5]. A fewbaﬁlomycinA1; CF, 5(6)-carbo-
co's modiﬁed Eagle's medium;
phosphocholine; FCS, fetal calf
i; LDH, lactate dehydrogenase;
I, mean ﬂuorescence intensity;
iodide; PM,plasmamembrane;
ne;SD,standarddeviation;SPPS,
l
39 049 827 6159.studies deal with neurotoxicity and eukaryotic cells interactions as
well [6–10].
A thorough investigation of the numerous biological effects of a
peptaibiotic has not yet been reported, partly because of the difﬁcult
chemical synthesis that hampered for years the use of the solid-phase
technique [11,12]. Therefore, we decided to perform a wide-range,
membrane/cell interaction study on the peptaibiotic trichogin GA IV
(Tric) [13,14] because of its accessible chemical synthesis [15], strong
proteolytic resistance [16] and well-known conformation [14] facilitat-
ing the acquisition of structure/activity relationships. Moreover, the
producing mold, Trichoderma longibrachiatum, widely present as a
plant saprophytic agent and in marine sediments, is an emerging
human pathogen. It is responsible for invasive mycosis, accompanied
with tissue necrosis, in immune-compromised individuals [17–20],
but also for local sinusitis in immune-competent patients [20,21].
Therefore, ascertaining the trichogin mechanism of action and its possi-
ble human cytotoxicity may have medical relevance.
Tric, whose primary structure is nOct-Aib-Gly-Leu-Aib-Gly-Gly-Leu-
Aib-Gly-Ile-Lol (nOct, n-octanoyl; Lol, 1,2-amino alcohol leucinol), is
able to permeate/modify model phospholipid membranes [14,22] by a
not yet fully understood mechanism. Its mixed α-/310-helix [13,23],
with the four Glys all lying on the same side, is slightly amphiphilic. Con-
sidering its short length (spanning about half of a membrane bilayer),
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[24], namely accumulating parallel to themembrane surface and, after a
threshold concentration, causing the membrane leakage. The nOct
group was found to play a crucial role in the interaction with model
lipid bilayer and erythrocytes as well [25]. Recently, the possible occur-
rence of a transmembrane orientation was also suggested [26,27]. No
information is available on the role of the other distinctive feature of
Tric and other peptaibiotics, that is the C-terminal alcohol moiety.
Although Tric was reported to display some antimicrobial action
[15,16,28] and to decrease the viability of keratinocytes at high doses
[15], no systematic studies are so far available on its cytotoxic efﬁcacy
and cellular selectivity so the deﬁnition of its real biological function is
still elusive. Thus, we investigated in detail the membrane perme-
abilization ability and the antibacterial, hemolytic, and cytotoxic
power of Tric using liposomal models, bacterial strains (two Gram−
and twoGram+), human cells (6 non-tumor and 4 tumor), and erythro-
cytes. Moreover, several Tric analogs variably modiﬁed at the N- and/or
C-termini and in the peptide backbone were synthesized to assess the
main structural features required for membrane/cell interactions and
to test the possibility of modulating cell-efﬁcacy and selectivity.2. Materials and methods
2.1. Peptide synthesis
The chemical structures of the trichogin analogs investigated are re-
ported in Table 1. The newly synthesized peptides were prepared by
SPPS or solution procedures according to published protocols [16,29].
All peptides, characterized by means of NMR and mass spectra, have a
purity greater than 96% (HPLC).2.2. Interactions with model membranes
2.2.1. Circular dichroism
CD spectrawere acquired on a Jasco (Tokyo, Japan) J-715 spectropo-
larimeter. Fused quartz cells (Hellma) of 1 mm path length were used.
The values are expressed in terms of [Θ]T and total molar ellipticity
(deg·cm2 dmol−1). A 100 mM solution of sodium dodecyl sulfate
(SDS) was used as solvent.Table 1
Peptide sequences of Tric and its analogs investigated. The molecular weight as determined by
n. Sequencesa
1 Oct-UGLUGGLUGILol
C-terminal modiﬁcations
2 Oct-UGLUGGLUGIL-OM
3 Oct-UGLUGGLUGIL-OH
N-terminal modiﬁcations
4 Ac-UGLUGGLUGILol
5 Fitc-UGLUGGLUGILol
N- and C-terminal modiﬁcation
6 Ac-UGLUGGLUGIL-OM
Replacement of Gly residue
7 Oct-UKLUGGLUGILol
8 Oct-UGLUGKLUGILol
9 Oct-UGLUGGLUKILol
10 Oct-UGLUGK(Fitc)LUG
Replacement of a Gly residue and C-terminal modiﬁcations
11 Oct-UKLUGGLUGIL-OM
12 Oct-UKLUGGLUGIL-CO
13 Oct-UGLUGKLUGIL-OM
14 Oct-UGLUGGLUKIL-OM
15 Oct-UGLUGK(Fitc)LUG
Bold indicates the modiﬁcation at the N- or C-terminal of trichogin.
a U, Aib; Fitc, ﬂuorescein isothiocyanate.
b Auto-SPPS, SPPS through an automatic synthesizer; man-SPPS, manual SPPS; sol. phase, pe
c The ﬁnal step (Fitc incorporation) was carried out in solution.2.2.2. Small unilamellar vesicle (SUV) preparation
DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine), DOPE (1,2-
dioleoyl-sn-glycero-3-phosphatidylethanolamine) and DOPG (1,2-
dioleoyl-sn-glycero-3-phosphatidylglycerol) were purchased from
Avanti Polar Lipids, Inc. (Alabaster, AL), while cholesterol (Ch) was a
Sigma-Aldrich (St. Louis, MO) product. The lipid mixture, DOPC/Ch
(7:3) or DOPG/DOPE (7:3), was dissolved in CHCl3 in a test tube,
dried under N2, and lyophilized overnight. The lipid ﬁlm was then
reconstituted with a solution of carboxyﬂuorescein (CF) dye in 30 mM
4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (Hepes) buffer
(pH 7.4) at room temperature for 1 h. The resulting multilamellar vesi-
cle suspension was sonicated (GEX 400 Ultrasonic Processor, Sigma) on
ice until the initially cloudy lipid dispersion became translucent. The
excess of ﬂuorescent dye was eliminated by gel ﬁltration on Sephadex
G-75 (Sigma). SUVs (Ø = 50–60 nm) were diluted to a concentration
of 0.06 mM with Hepes buffer (5 mM Hepes, 100 mM NaCl, pH 7.4).
The SUVs were stored at 4 °C and used within 24 h.
2.2.3. Leakage from lipid vesicles
The peptide-induced leakage from SUVs of lipid composition
DOPC/Ch (7:3) or DOPG/DOPE (7:3) was measured at 293 K using the
CF-entrapped vesicle technique and a Perkin ElmermodelMPF-66 spec-
troﬂuorimeter. The phospholipid concentration was kept constant
(0.06 mM), and increasing [peptide]/[lipid] molar ratios were obtained
by adding aliquots of methanol solutions of peptide at different concen-
trations. The ﬁnal methanol concentration was kept below 5% by vol-
ume. After rapid and vigorous stirring, the time course of ﬂuorescence
change corresponding to CF escape was recorded at 520 nm (10-nm
band pass) with λexcof 488 nm (10-nm band pass). A 1% T emission ﬁl-
ter was applied. The percentage of released CF at time twas determined
as (Ft− F0) / (FT− F0) × 100, with F0 = ﬂuorescence intensity of vesi-
cles in the absence of peptide, Ft = ﬂuorescence intensity of vesicles at
time t in the presence of peptide, and FT = total ﬂuorescence intensity
determined by disrupting the vesicles by addition of 50 μl of a Triton
X-100 aqueous solution (10%). The kinetics experiments were stopped
at 20 min.
2.3. Antibacterial activity
MICs of the peptides were determined using the brothmicrodilution
method. Two-fold serial dilutions (from 1 to 64 μM) of each peptide,ESI–MS is given only for the newly synthesized compounds.
Abbreviation Synthesisb MWcalcd MWfound
Tric [28] – –
e Tric-OMe [25] – –
Tric-COOH Auto-SPPS 1080.70 1080.65
Ac-Tric Auto-SPPS 892.62 892.63
FITC0-tric Auto-SPPS 1329.66 1329.67
e Ac-Tric-OMe [25] – –
K2 Auto-SPPS 1137.79 1137.84
K6 [28] – –
K9 Auto-SPPS 1137.79 1137.84
ILol K6FITC Auto-SPPSc 1527.83 1527.87
e K2-OMe [28] – –
OH K2-COOH Auto-SPPS 1151.77 1151.78
e K6-OMe Sol. phase 1165.78 1165.83
e K9-OMe [28] – –
IL-OMe K6FITC-OMe Sol. phase 1554.83 1554.85
ptide synthesis in solution.
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were prepared in LBmedium and 50 μL per well was arranged in sterile
96-well plates (Falcon). Then, an aliquot (50 μl) of bacterial cell suspen-
sion was added to each well, at a ﬁnal concentration of 5 × 105 CFU/ml.
After incubation for 8 h or 24 h at 37 °C, the inhibition of bacterial
growth was assessed and the MIC endpoint was deﬁned as the lowest
concentration of the antimicrobial peptide that completely inhibited
bacterial growth. The effect of the peptides on the growth of four bacte-
rial strains was examined as follows: a bacterial cell suspensionwith an
OD at 625 nm of 0.05 was prepared in LB medium, diluted 1:100 in LB
and then allocated in 96-well plates and after adding different concen-
trations (1–64 μM) of the peptides, the bacterial cultures were grown
for up to 24 h, recording the absorbance at 620 nm at 1 h intervals
with a Microplate ELISA reader (Amersham Biosciences) to assess the
cell growth. Vehicle solvent (EtOH) was used as control at the same
concentrations reached in peptide containing media.2.4. Cell isolation and culture
HeLa, A431 and CCD34-Lu cells were maintained in DMEM (Gibco),
A549 in F12 medium (Gibco) and HL60 in RPMI medium (Gibco),
supplemented with 10% FCS (Euroclone) and antibiotics (penicillin
and streptomycin, Invitrogen) at 37 °C in a humidiﬁed atmosphere
containing 5% (v/v) CO2; cells were split every 2–3 days.
Human monocytes, PMNs and lymphocytes were puriﬁed from
buffy coats of healthy donors, kindly provided by the Centro
Immunotrasfusionale, Hospital of Padova. Brieﬂy, for monocyte puriﬁ-
cation, buffy coats were subjected to two sequential centrifugations
on Ficoll and Percoll gradients (GE Healthcare); residual lymphocytes
were removed by incubation in 2% FCS RPMI at 37 °C and subsequently
removed by washing. Unless otherwise speciﬁed, cells were kept at
37 °C in a humidiﬁed atmosphere containing 5% (v/v) CO2 in RPMI-
1640 supplemented with 10% FCS. For PMN puriﬁcation, the pellet of
cells obtained after the centrifugation on the Ficoll gradient was sub-
jected to dextran erythrocyte precipitation; residual erythrocytes
were removed by hypotonic lysis in 155 mM NH4Cl, 10 mM KHCO3,
and 100 mMNa2EDTA at pH 7.4 and cells were cultured in RPMI medi-
um, supplemented with 10% FCS. For lymphocyte preparation, buffy
coats were incubated with 50 μl/ml of Rosette Sep® Human T Cell En-
richment Cocktail (StemCell Technologies). Bloodwas then centrifuged0
25
50
75
100
%
C
F
peptide concentration (µM)
 Ac-Tric
 Tric-COOH
 Tric
 Tric-OMe
A
0,0 2,5 5,010 15 20 0 5 10 15
0
10
20
30
%
 h
em
ol
ys
is
peptide conc
 Tric
 Tric
 Tric
 Ac-T
B
Fig. 1. Interaction of Tric analogs with model and cell membranes. A) CF leakage from SUVs (D
B) Induction of hemolysis by different Tric analogs after 2 h incubation with fresh red blood
water. C) Far-UV CD spectra of trichogin GA IV and its analogs in 100 mM SDS aqueous solutioover a Ficoll gradient and cells were cultured in RPMI medium, supple-
mentedwith 10% FCS. To obtainmacrophages, puriﬁedmonocyteswere
cultured for seven days in 20% FCS RPMI supplemented with 100 ng/ml
of M-CSF (Immunological Sciences). Dendritic cells were obtained by
culturing puriﬁed monocytes in 10% RPMI containing 50 ng/ml
GM-CSF and 20 ng/ml IL-4 (Peprotech).2.5. MTS and LDH assays
The day before the experiment, A431, HeLa, A549 and CC34-Lu cells
were detached by trypsin treatment (Gibco), counted and seeded
onto 96 wells/plate (8 × 103 cells/well, Falcon). After puriﬁcation,
monocyteswere seeded onto 96 wells/plate (2 × 106 cells/well), left to ad-
here to the plastic and immediately treated with stimuli. PMNs, lympho-
cytes (2 × 106 cells/well) and HL60 cells (40 × 103) were seeded onto
cell plates and subsequently treated. Different peptideswere diluted in cul-
turemedium(from20μMto1 μM)andadded to the cells. As apositive con-
trol, cellswere treatedwithmediumwithout stimuli. After 24 h-treatment,
the cell supernatant was collected for subsequent assay (LDH assay) and
cells were tested using a CellTiter 96® AQueous One Solution Reagent
(Promega). Plateswere readwith an ELISA reader (AmershamBiosciences)
at 492nm.EC50 (the concentrationof drugwhere50%of cells died)was cal-
culated for eachpeptide andeachkindof tested cell, after anon-linear logis-
tic ﬁt of data means. For LDH assays, 50 μl aliquots of the cell supernatant
were tested with a CytoTox 96® Non-Radioactive Cytotoxicity Assay kit
(Promega). EC50 (the concentration of drug that induced the lysis of 50%
of the total cell number) was calculated for each peptide and each kind of
tested cell, after a non-linear logistic ﬁt of data means.2.6. Hemolysis assay
Fresh citrated blood was mixed at 1:1 (v/v) ratio with different
concentrations of Tric and its analogs (0–16 μM) in 150 mM NaCl.
Blood diluted with distilled water or with PBS was used as negative or
positive control, respectively. Samples were incubated at 37 °C for 2 h
and then centrifuged at 2600 rpm for 7 min. Supernatants were collect-
ed and incubated at room temperature for 30 min to allow hemoglobin
oxidation. Then oxyhemoglobin concentration was measured spectro-
photometrically at 620 nm.-200
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HeLa cells were seeded on a plastic plate the day before the experi-
ment, while HL60 cells were directly used. Cells were treated for 18 h
with different trichogin analogs (up to 20 μM), then they were washed
with PBS, detached with trypsin (in the case of HeLa cells), centrifuged
at 200 g for 5 min, re-suspended in 50 μl of incubation buffer (Roche)
and incubated for 15 min at 37 °C with 2 μl of Annexin-V-Fluos
(Roche). Cells were ﬁnally diluted in 250 μl of the incubation buffer and
15 μl of propidium iodide (PI) (Sigma)was added to each sample just be-
fore the acquisitionwith FACSCanto® (Beckton Dickinson). Percentage of
live (Annexin V−/PI−), apoptotic (Annexin V+/PI−), oncotic (AnnexinHeLa HL60
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Fig. 2. Cytotoxic effects of Tric and its analogswith either a N- or C-terminalmodiﬁcation. A)HeL
FITC and propidium iodide and subsequently subjected to FACS analysis. Results were express
quired by FACS. B) EC50 values (such as peptide doses resulting in a 50% of the maximum effec
and expressed as means± SD of four experiments run in duplicate. *b0.05 with respect to trich
the percentage of cytotoxic activity with respect to wt Tric, whose activity was ﬁxed to 100%
shown).V−/PI+) and late apoptotic/abortive oncotic (Annexin V+/PI+) cells of
the total (106 cells) was calculated using FACSDiva Software.2.8. Binding and uptake studies
The day before the experiment, HeLa and A431 cells were detached
by trypsin treatment and seeded on a 24-well plate (1 × 105 cells/well).
On the day of the experiment the different cells (HeLa, A431,
monocytes, PMNs, macrophages and dendritic cells) were incubated
for 2 h with different FITC-labeled trichogin analogs (from 0.075 to
5 μM), both at 37 °C (binding and endocytosis) and 0 °C (binding) in0
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tion on Tric uptake, baﬁlomycin A1 (BafA1) was used as an inhibitor of
endosome acidiﬁcation. Stock solution of BafA1 was prepared in di-
methyl sulfoxide (DMSO) at concentrations of 200 μM. To examine
the energy-dependence of Tric uptake, sodium azide (Sigma) and 2-
deoxy-D-glucose (DOG, Sigma) were used. Inhibitors were dissolved
on the day of each experiment in Dulbecco-PBS (D-PBS, Gibco). Cells
were then incubated in the presence of inhibitors for 30 min at 37 °C
in D-PBS containing 10% FCS (100 nM BafA1 or 10 mM sodium azide
and 5 mM DOG); thereafter, cells were washed three times in PBS,
and were incubated for 2 h with 5 μM of ﬂuorescent trichogin analogs
in D-PBS buffer supplementedwith 10% FCSwith orwithout each inhib-
itor. Cells were then washed in PBS and resuspended in FACS buffer
(PBS, 1% FBS) and 10,000 events per sample were analyzed using a
FACSCanto® analyzer (Becton Dickinson). Dead cells were excluded
from FACS analysis by adding propidium iodide.
2.9. Confocal microscopy
Macrophages (2× 106 cells/well) and HeLa cells (1 × 105 cells/well)
were seededon cover glasses and incubatedwith 5 μMK6-FITC for 2 h at
37 °C or at 0 °C. Unﬁxed cells were brieﬂy rinsed in PBS and directly an-
alyzed under a confocal microscope (SP2 Leica). Untreated cells were
used as control. Images were acquired with different ﬂuorescence ﬁl-
ters; representative pictures were collected as Tiff ﬁles and processed
with standard imaging programs.
2.10. Mathematical and statistical analyses
All mathematical and statistical analyses were performed using the
analysis and statistic packages of the Microcal Origin 8 software. EC50
values of cytotoxicity and hemolysis were obtained after ﬁtting
dose–response data non-linearly with logistic curves [Y=A2 + (A1–
A2)/(1+(x/x0)p)] from statistically signiﬁcant convergent curves. MTS
assay data were normalized as % of control (A2 = 100, A1 = 0). LDH
and hemoglobin release assay data were normalized as % ofMa
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Fig. 3. Binding and internalization of FITC-labeled trichogin analogs to human cells. A) Differen
associated ﬂuorescencewasmeasured by FACS. Numbers above histograms indicate the percen
100%. B) Confocal microscopy on HeLa andmacrophages. Cells, previously seeded onto cover gl
OMe, washed with PBS and then directly analyzed by confocal microscopy. Arrowheads indicamaximal extracellular release induced by distilled water (A2 =back-
ground % release, A1 = 100%). Normal (Gaussian) distribution of data
was checked and conﬁrmed by the Shapiro–Wilk test (0.05 level). Sig-
niﬁcance of the differences between means (0.05 level) was evaluated
by two samples or paired t test, when applicable, and by ANOVA analy-
sis plus Bonferroni, Scheffe and Tukey tests.3. Results
3.1. Permeation of membranes
To assess the possible role of the C-terminal alcohol group in model
membrane damage, we quantiﬁed the efﬁcacy of various Tric synthetic
analogs to induce the leakage of carboxyﬂuorescein (CF) entrapped in
small unilamellar vesicles (SUVs). SUVs were made of zwitter-ionic
phospholipid and cholesterol (DOPC/Ch 7:3), considered a proxy of
the eukaryotic lipid monolayer facing the extracellular space. We also
measured the release of hemoglobin from erythrocytes (Fig. 1A, B).
Liposomal leakage, in agreement with previous evidence, was not
induced by peptides lacking the N-terminal nOct moiety. On the other
hand, replacement of the primary alcohol (\CH2OH) by a methyl
ester group (Tric-OMe) or by a carboxylic acid (Tric-COOH) showed a
partial or a complete activity inhibition, respectively (Fig. 1A). As previ-
ously reported, the hemolytic effect of Tric was much reduced as com-
pared to the liposomal leakage (threshold: 8 μM, 25% hemoglobin
release at 32 μM). However, in spite of these different efﬁcacies in the
two systems, we observed a similar reduction of the activity of the
other Tric analogs. In fact, themembrane destabilization of erythrocytes
by Ac-Tric and Tric-COOH was totally absent, and that induced by Tric-
OMewas ~60–70% inhibited (threshold: 16 μM; 8% hemoglobin release
at 32 μM) compared to Tric (Fig. 1B).
Far-UV CD spectra in 100 mM SDS aqueous solution, a membrane-
mimetic environment (Fig. 1C), show two negative maxima at about
205 and 222 nm of moderate intensities and a positive maximum at
about 195 nm [30] for all peptides investigated. This observation
indicates that they all adopt a right-handed, mixed α-/310-helicalLa
[98]
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the different behaviors with liposomal and erythrocyte membranes
are reasonably ascribed to the moieties located at the peptide extremi-
ties, rather than to the peptide conformation.co
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percentage of dead cells with respect to not treated with the indicated peptides. Data are the m3.2. Cellular effects of Tric and its analogs modiﬁed at the N- and/or
C-termini
Having established the relative potencies of Tric and its analogs to
destabilize membranes, we engaged in assessing their toxic effects on
bacteria and eukaryotic cells. First, we observed that the peptides dis-
play no antibiotic activity up to 64 μM (not shown). This apparent lack
of effects on prokaryotic cells, in line with previous observations [16],
poses the problem of the real activity and selectivity of Tric. To ﬁll this
gap, we initially tested the killing of two human cancer-derived
cell lines (HeLa and HL60) after 24 h by a dose of Tric able to fully
permeabilize the model liposome membrane (20 μM). Surprisingly,
FACS analysis showed that Tric effectively induced a necrotic phenotype
in HeLa cells, characterized by the permeabilization of their plasma
membrane to PI, and an abortive/late apoptotic one in HL60, indicated
by both leakage to PI and Annexin V labeling of surface-exposed PS
(Fig. 2A). In good correlation with their membrane permeation poten-
cies, Tric-COOH and Ac-Tric were very weak or not cytotoxic (90–95%
and N98% inhibition in both cell types, respectively), while Tric-OMe
showed a marked reduction of its cytotoxicity on both cell types
(~70–90% inhibition compared to Tric). These data further support the
intriguing possibility that not only the N-terminus nOct but also the
C-terminus\CH2\OH of Tric may play a speciﬁc action in the interac-
tionwith and destabilization of eukaryotic cells and, consequently, in its
intoxication mechanism.
To consolidate and extend this indicationwe analyzed the cytocidal ef-
fects of Tric and its derivatives on a wider range of human cells, both
healthy andneoplastic: (i) threeprimaryhumanblood cells (lymphocytes,
PMNs, monocytes), (ii) two types of in vitro differentiated, monocyte-
derived, antigen presenting cells (macrophages and dendritic cells),
(iii) the in vitro stabilized line CCD34Lu (from the human normal lung),
(iv) the monocyte-like HL60 cell line from human myeloid leukemia,
and (v) three tumor derived non-leukocyte cell lines: HeLa (human
ovary sarcoma), A431 (human epidermoid carcinoma) and A549 (human
lung carcinoma). Toxicity was evaluated quantitatively by dose–response
curves up to 20 μM peptide concentration after a 24 h incubation using as
parameter thedecreaseofMTS reduction ratebymitochondriaor theextra-
cellular release of the cytosolic enzyme LDH. Data showed that Tric has a
similar cytotoxic effect on both cancer-derived and non-tumoral cells
with mean (±SD) EC 50% values of 5.8 (±0.41) μM for the MTS assay
and ~9 (±2) μM for the LDH assay (Fig. 2B and Fig. S1). Again, Tric-COOHB
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d cytotoxicity towards cells. A) HeLa cells were pre-treated or not for 30min at 37 °Cwith
and incubated for 2 hwith 5 μMof K6FITC-OMe, both at 37 °C and 0 °C (not shown). Then,
f MFI with respect to the control cells, whose MFI was ﬁxed to 100%. B) HeLa cells were
ated by FACS count, ﬁxing the time of acquisition at 60 s; results were expressed as the
eans ± SE of three experiments run in duplicate.
Table 2
MICs (μM ± SE; N ≥ 4; peptides dose range: 0–64 μM)after 24 h against twoGram+ and
two Gram− bacterial strains.
Compounds S. aureus S. epidermis P. aeruginosa E. coli
Tric N64 N64 N64 N64
K2 3 ± 1.4 4.3 ± 2 58 ± 16 24 ± 17.1
K2-OMe 6 ± 2.8 6 ± 2.8 N64 32 ± 0
K2-COOH 32 ± 0 48 ± 22 N64 N64
K6 3 ± 1.7 4 ± 2 N64 16 ± 0
K6-OMe 4 ± 1 6 ± 2.8 32 ± 0 32 ± 0
K9 5.3 ± 2.1 4.7 ± 1.6 57 ± 16 32 ± 17.5
K9-OMe 3 ± 1.4 1 ± 0.5 N64 32 ± 0
140 R. Tavano et al. / Biochimica et Biophysica Acta 1848 (2015) 134–144and Ac-Tric were not cytotoxic. Eventually, the replacement of the C-
terminal \CH2OH with a methyl ester (Tric-OMe) determined a partial
but signiﬁcant inhibition of Tric cytotoxic action in all cells (mean inhibi-
tion = 54–60%), resulting in shifts of the mean EC 50% values to 13 ± 2.2
for the MTS assay and to 22 ± 3 for the LDH assay.
3.3. Cell binding and endocytosis of Tric and its analogs
The data abovehighlight the novelﬁnding that Tric is indeed cytotoxic
tomanyhuman cells at doses completely devoid of antibacterial or hemo-
lytic effects. Moreover, in agreement with CF liposomal leak, it is evident
that the C-terminal alcoholic function plays a crucial role in cell killing.
To address this intriguing issue, we explored the mechanism of
human cell intoxication by Tric.We ﬁrst investigated the role of the cru-
cial N-terminal group on peptide–cell interactions by measuring cell
capture of two ﬂuorescent Tric analogs (Table 1): FITC0-tric, in which
nOct is substituted by the ﬂuorescent probe FITC, and K6FITC-OMe, in
which nOct is present and the ﬂuorescent label is located on the side
chain, linked to a Lys ε-amino group. This allowed us to quantitatively
compare cell association by FACS analysis and to assess the contribution
of the nOct to it. Experiments were performed in HeLa cells, A431 cells,
monocytes, PMNs, lymphocytes, macrophages, and dendritic cells at
two critic temperatures: 0 °C, allowing binding but not compatible
with membrane endocytosis and 37 °C, the physiological temperature
also permitting membrane endocytosis. Our results (Fig. 3A) show
that cell association of the nOct-bearing Tric analog (K6FITC-OMe)
after a 2 h incubation is always improved at 37 °C (mean fold increase±
SD = 3.85 ± 1.1), although characterized by different intensities
depending on the cell type. On the contrary, cell association of the
nOct lacking FITC0-tric in the same conditions was relatively smaller
and similar at either 0 °C or 37 °C. Confocal microscopy of HeLa cells
andmacrophages conﬁrmed that K6FITC-OMe signal is faint andmostly
located on the cell plasma membrane at 0 °C, while much stronger and
localized in intracellular compartments, resembling endosomes, at
37 °C (Fig. 3B). These data suggest that the peptide backbone of Tric0
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Fig. 6. Interaction of K-substituted Tric analogs with model membranes. A) Far-UV CD spectra o
0.1 mM). B) CF leakage from SUVs (DOPC/Ch 7:3 or PE/PG 7:3 — lipid concentration 60 μM) indoes not mediate an effective binding and internalization to human
cells. On the contrary, the nOct is necessary to ensure the efﬁcient
association in all tested cells, especially at 37 °C. To assess the inﬂuence
of the C-terminal alcohol on the trichogin–cell interactionwe compared
peptide accumulation in dendritic cells of K6FITC and K6FITC-OMe
(Fig. 4). While the reduced cell binding of the two analogs at 0 °C was
similar, and comparable to the nOct lacking FITC0-tric, the cell associa-
tion increase at 37 °C was remarkably more intense in the presence of
the C-terminal alcohol. Collectively, these data suggest that simple
binding to the cell plasma membrane at 0 °C is mainly mediated by
the peptide backbone of Tric, and poorly modulated by the nOct and
the terminal primary alcohol. On the other hand, cellular internalization
triggered at 37 °C essentially requires the nOct but is further up-
modulated by the C-terminal\CH2\OH.3.4. Effect of endocytosis blockade and of endolysosomal neutralization on
Tric cytotoxicity
Having observed that Tric binds more efﬁciently and is strongly
internalized by human cells at 37 °C and that both the nOct and thetrichogin GA IV
K9
K2
peptaibol concentration (μM)
peptaibol concentration (M)
trichogin GA IV K9K2 
PC/Ch (7:3)
PE/PG (7:3)
2,5 5,0 7,5 10,0
2,5 5,0 7,5 10,0
f trichogin GA IV and its analogs in 100mM SDS aqueous solution (peptide concentration:
duced by increasing peptide concentrations.
141R. Tavano et al. / Biochimica et Biophysica Acta 1848 (2015) 134–144primary terminal alcohol are important for such effect, we investigated
whether the cytotoxic effect requires or not endocytosis. To test this we
used BafA1, a drug which selectively neutralizes the lumen of
endosomes by blocking the V-ATPase, so affecting their function and
maturation [32]. In addition we depleted cellular ATP by DOG plus
sodium azide incubation to prevent cellular internalization [33].
Fig. 5A shows that, as previously observed, after a two hour incubation
K6FITC-OMe can associate effectively to cells at 37 °C and that blocking
endocytosis or endolysosomal acidiﬁcation did not affect such binding.
Strikingly, however, the cytotoxic action of K6FITC-OMe and of the na-
tive Tric, measured in parallel by counting the cell number by FACS,
was prevented by endocytosis blockade and partially inhibited by neu-
tralization of endolysosomes (Fig. 5B). These observations indicate that
the increased internalization of Tric at 37 °C is the consequence of an in-
creased association of the peptide to the cell plasma membrane at this
temperature. In addition, they demonstrate that the peptide externally
bound to the plasma membrane does not damage the lipid bilayer. On
the contrary, cell intoxication and eventual cell lysis require Tric inter-
nalization in acidic endosomes.
3.5.Modulation of cytotoxic and antibacterial activities of Tric by increasing
the cationic amphipathic properties of its helical peptide backbone
It has been previously shown that the antibacterial effects of Tric can
be improved by the substitution of glycines with cationic lysines [28].
With the aim of further testing the cell selectivity of Tric,we determined
how the insertion of a Lys residue affects structure, liposomal leakage,
hemolysis and human cell killing and association.
Single substitution of Gly for Lys in position 2, 6 or 9 of Tric did not
alter signiﬁcantly its helical structure, according to CD spectra in
membrane-mimetic SDS micelles (Fig. 6A).
Interestingly, dose–response analysis of CF leak from liposomes
mimicking either eukaryotic (DOPC/Ch) or prokaryotic (PE/PG)
membranes revealed important differential effects (Fig. 6B). First,
Tric was signiﬁcantly more effective on PC/Ch liposomes (EC 50%
effect ~2 μM) than on PE/PG ones (EC 50% effect ~9 μM). Second,
while the leakage effect was not signiﬁcantly modiﬁed by Lys
mono-substituted Tric analogs in eukaryotic like-liposomes, the in-
troduction of positively charged residue improved the CF leak in-
duced by the peptide analogs in negative, prokaryotic like-
membranes (EC 50% ~6 μM).
In agreementwith liposomal data,we show that Lys-monosubstituted
Tric analogs effectively block the growth of Gram+Staphylococcus aureus
and Staphylococcus epidermidis (MIC range: 1–6 μM), while are less active
on Gram−Escherichia coli (MIC range 16–32 μM) and Pseudomonas
aeruginosa (MIC range: 32–64 μM) (Table 2). In addition, we here
also demonstrate that replacement of the C-terminal \CH2\OH
with\COOMe is irrelevant for the anti-Gram+ effect of Lys-substituted
Tric,while its substitutionwith\COOH strongly reduces the antibacterial
effects on Gram+.
Surprisingly, we found (Fig. 7A and Fig. S2) that, on the contrary, the
Lys-monosubstituted Tric analogs were equally or slightly less effective
than Tric in killing human nucleated cells, again in good agreementwith
data obtained with “eukaryotic-mimetic” liposomes. Once again, the
substitution of the C-terminal \CH2\OH with \COOH or a methyl
ester was found to strongly or signiﬁcantly reduce cytotoxicity. PI/
Annexin V labeling experiments conﬁrmed that an optimal cytotoxic ac-
tion of Lys-monosubstituted Tric on human cells still requires the alco-
hol (Fig. 7B). Eventually, we showed a similar inhibition of the
destabilization of red blood cell plasma membrane induced by LysTric
at concentrations N8 μM by the substitution of the C-terminal primary
alcohol with a COOH or a methyl ester (total ablation and ~60% inhibi-
tion, respectively) (Fig. 7C). A schematic summary to better appreciate
the differential modulation of the cytotoxic and antibacterial activities
of Tric by chemical modiﬁcations interesting its α-helix and the C-
terminus is shown in Fig. 7D.4. Discussion
We here present the novel observation that the short peptaibiotic
Tric from T. longibrachiatum, normally assumed to be an antimicrobial
peptide, is, on the contrary, an effective cytotoxin at doses devoid of an-
tibacterial effects. Several primary and cancer-derived human cell types
were indeed lysed by trichogin with similar efﬁcacies. This represents a
new paradigm, challenging the previous suggestions that peptaibols are
just antimicrobial agents, at least in the case of trichogin.
In addition, based on structure–function correlation analysis, we un-
derscore that not only the N-terminal nOct chain of Tric, but also the C-
terminal\CH2\OHmoiety plays amajor role in human cell killing. We
in fact showed for the ﬁrst time that the presence of this distinctive and
unique feature of peptaibiotics signiﬁcantly improves the efﬁcacy of Tric
to permeate artiﬁcial (liposomes) and natural (erythrocytes) mem-
branes. Even more importantly from the biological point of view, the
\CH2\OH group signiﬁcantly contributed to the exertion of optimal
cytotoxic effects of Tric on human cells.
Our data are consistent with a recent study in model membranes
[34] indicating that the C-terminal OH group of Tric mostly interacts
with the glycerol moiety, and to a minor extent with the phosphate
groups via H-bonding interactions. These interactions may contribute,
together with the ones driven by N-terminal nOct, to the Tric induced
bilayer deformation and thinning eventually leading to membrane per-
meabilization. In fact, the substitution of the C-terminal alcohol with a
methyl ester (Tric-OMe) eliminates the possibility of establishing
these interactions. Moreover, the presence of a C-terminal COOH
group instead of the \CH2\OH (Tric-COOH), negatively charged at
physiological pH, would determine an electrostatic repulsion with the
lipid phosphate groups, strongly disfavoring membrane interaction
and effects, as observed in this study.
The existence of eukaryotic-speciﬁc intoxicationmechanisms of Tric
is further supported by our observation that the artiﬁcial improvement
of the amphipathic and cationic features of thepeptideα-helix of Tric by
introducing K residues, known to abruptly increasing Tric anti-bacterial
effects, particularly of the two Gram+ bacteria here analyzed (S. aureus
and S. epidermidis), does not improve the sensitivity of any human
cell type tested to Tric. Moreover, while the OMe analogs of Lys-
monosubstituted Tric are as effective as the \OH containing ones in
antibacterial assays, they displayed a further mitigated killing efﬁcacy
of human cells and a reduced hemolytic action.
Overall, these data point to a peculiar role of the terminal OH in the
interaction of Tric with the eukaryotic cell plasmamembrane, irrelevant
in the interaction with the bacterial one. To understand in more detail
themechanism of human cell killing by Tric,we analyzed its cell binding
and endocytosis and assessed the importance of these two processes for
the induction of the eventual cell lysis. We found that the backbone of
trichogin is not enough to ensure effective association to all human
cell tested and that, on the contrary, the presence of both the
N-terminal nOct and the C-terminal alcohol is always necessary for its
effective binding to the cell plasma membrane and for the subsequent
endocytosis at 37 °C. Prevention of endocytosis by energy depletion
not only revealed that both the nOct and the C-terminal alcoholmediate
the temperature dependent binding to cell plasma membrane, but also
proved that this initial interaction is not enough to determine its desta-
bilization and the cell death. The neutralization of endosome acidiﬁca-
tion did not alter the total Tric cell capture but partially inhibited its
cytotoxic effect. Again, this observation indicates that the transport of
Tric in internalization vesicles is important for the induction of cytotoxic
effects. These data may suggest that cytotoxicity of Tric is stronger in
human eukaryotic cells, compared to bacteria, thanks to the endocytic
step. Indeed, the current models of membrane destabilization by Tric
suggest a high cooperative interaction between peptidemolecules lead-
ing to the formation of toxic structures, possibly transmembrane
permeabilizing aggregates, after reaching a critical membrane concen-
tration [35]. It may therefore be that the critical concentration of
142 R. Tavano et al. / Biochimica et Biophysica Acta 1848 (2015) 134–144trichogin necessary formembrane damage is not obtained in the plasma
membrane at the investigated peptide concentrations, but is only
reached after endocytosis and accumulation in endolysosomes. The
eventual disruption of endo-lysosomal compartments may then sec-
ondarily trigger necrosis or apoptosis, as observed. This may explain
the partial inhibitory effect obtained by neutralizing the acidity of an in-
tracellular compartment on Tric cytotoxic action, since it is known that
maturation of the endosomes is slowed in these conditions. In this view
themembrane permeation of human cells leading to cell lysis, shown in
this study, would not be the direct consequence of the Tric plasma
membrane destabilization, but rather a secondary non-speciﬁc effect
typical of the necrosis (or abortive apoptosis) triggered by cell-
internalized Tric (see model in Fig. 8). Our model suggests the hypoth-
esis that the general presence of a C-terminal\CH2OH in peptaibiotics
may be justiﬁed by its need for an optimal interaction with eukaryoticK
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(\OMe or\COOH).membranes, being necessary for effective binding to the plasma mem-
brane and for the subsequentmembrane destabilization after a critically
needed internalization step. This may shed a new light on the role of
Tric, and possibly other peptaibiotics in nature, and suggests that
this peptide may be a pathogenic factor in human and other mammal
opportunistic infections by T. longibrachiatum.
5. Conclusions
i) The membrane-active peptaibiotic Tric from the opportunistic
mold T. longibrachiatum is a wide-spectrum anti-human cyto-
toxin, acting at concentrations lacking any antibacterial activ-
ity; our results suggest that this molecule might be a
pathogenic/virulence factor in human opportunistic infec-
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phase that requires the acidic condition in the lumen of these compartments and that also req
permeation to PI and leak of larger cytosolic components, and eventually cellular lysis follows th
to necrotic cell death.necessary for efﬁcient membrane association in a temperature
dependent fashion (present at 37 °C), followed by endocytosis
and killing of human cells.binding (37°C)
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the cell plasmamembrane (step A) requires both the N-terminal Octyl and the C-terminal
y depletion does not affect the plasma membrane binding but protects cells from the Tric
the formation of aggregates able to damage endosomal/lysosomal membranes (step C), a
uires both the nOctyl and the primary alcohol. Plasma membrane damage is indirect with
e intracellular action of Tric and is preceded bymitochondrial activity inhibition, similarly
144 R. Tavano et al. / Biochimica et Biophysica Acta 1848 (2015) 134–144iii) The internalization in acidic endosomes is required for the
induction of a human cell lytic death by Tric.
iv) Taking advantage from this information, we demonstrated that
the improvement of the cationic and amphipathic feature of the
Tric backbone (by Lys insertion) together with the \CH2OH
replacement (by COOMe) strongly boosts its scanty anti-Gram+
activity, mitigating at the same time adverse cytotoxic effects on
human cells.
v) Thus, the remarkably tunable bioactivity of Tric may open the
way to a new generation of potentially interesting antibiotic
and, possibly, antitumor agents.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamem.2014.10.005.
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